Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206132389> ?p ?o ?g. }
- W4206132389 endingPage "151" @default.
- W4206132389 startingPage "143" @default.
- W4206132389 abstract "Children's Oncology Group study ACNS1123 tested the efficacy of reduced dose and field of radiation therapy (RT) for patients with localized nongerminomatous germ cell tumors (NGGCT) who achieved a complete (CR) or partial response (PR) to chemotherapy. Here, we evaluate the quality of RT and patterns of failure for patients eligible for reduced RT in this phase 2 trial.Patients with localized NGGCT with CR/PR after induction chemotherapy received reduced RT to 30.6 Gy whole ventricular irradiation and 54 Gy tumor-bed total dose. An atlas was provided to assist with complex RT volumes. Early interventional review was performed for the initial RT plan. Complete RT plans for all patients and images of relapsed patients were centrally reviewed at completion of therapy.Between May 2012 and September 2016, 107 eligible patients were enrolled and 66 achieved a CR/PR after induction chemotherapy (± second-look surgery) and were eligible for reduced RT. Median follow-up was 4.4 years. Median age was 11.0 years (3.7-21.6), and 75% were male. Progression-free survival and overall survival at 4 years were 87.9% ± 4.0% and 92.4% ± 3.3% for 66 evaluable patients, respectively. Eight patients relapsed: 6 with isolated spinal relapse and 2 with disease in the brain and spine. After central review, 62 (94%) patients had RT targets contoured and dose delivered per protocol. None of the patients with deviations (n = 4) have progressed.Patterns of failure suggest the spine is at risk for recurrence for patients with localized NGGCT who receive reduced RT after a CR/PR to induction chemotherapy. Although survival data are encouraging, the pattern of failure has influenced the next prospective trial design. RT compliance was excellent despite complexity of radiation volumes, suggesting that providing visual guidance in the form of an online atlas contributes to higher quality RT plans." @default.
- W4206132389 created "2022-01-26" @default.
- W4206132389 creator A5002952095 @default.
- W4206132389 creator A5012736355 @default.
- W4206132389 creator A5014542884 @default.
- W4206132389 creator A5020922940 @default.
- W4206132389 creator A5024356241 @default.
- W4206132389 creator A5047930377 @default.
- W4206132389 creator A5050235191 @default.
- W4206132389 creator A5055909207 @default.
- W4206132389 creator A5056658906 @default.
- W4206132389 creator A5065578155 @default.
- W4206132389 creator A5066253784 @default.
- W4206132389 creator A5067969166 @default.
- W4206132389 creator A5070449446 @default.
- W4206132389 creator A5075545081 @default.
- W4206132389 creator A5079216912 @default.
- W4206132389 creator A5080426159 @default.
- W4206132389 creator A5085032736 @default.
- W4206132389 date "2022-05-01" @default.
- W4206132389 modified "2023-10-17" @default.
- W4206132389 title "A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors" @default.
- W4206132389 cites W1965779893 @default.
- W4206132389 cites W2032087325 @default.
- W4206132389 cites W2108795808 @default.
- W4206132389 cites W2149296823 @default.
- W4206132389 cites W2157042773 @default.
- W4206132389 cites W2161501889 @default.
- W4206132389 cites W2610372030 @default.
- W4206132389 cites W2727345885 @default.
- W4206132389 cites W2735938895 @default.
- W4206132389 cites W2781674579 @default.
- W4206132389 cites W2961107284 @default.
- W4206132389 cites W2977021423 @default.
- W4206132389 doi "https://doi.org/10.1016/j.ijrobp.2021.12.166" @default.
- W4206132389 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34990779" @default.
- W4206132389 hasPublicationYear "2022" @default.
- W4206132389 type Work @default.
- W4206132389 citedByCount "7" @default.
- W4206132389 countsByYear W42061323892022 @default.
- W4206132389 countsByYear W42061323892023 @default.
- W4206132389 crossrefType "journal-article" @default.
- W4206132389 hasAuthorship W4206132389A5002952095 @default.
- W4206132389 hasAuthorship W4206132389A5012736355 @default.
- W4206132389 hasAuthorship W4206132389A5014542884 @default.
- W4206132389 hasAuthorship W4206132389A5020922940 @default.
- W4206132389 hasAuthorship W4206132389A5024356241 @default.
- W4206132389 hasAuthorship W4206132389A5047930377 @default.
- W4206132389 hasAuthorship W4206132389A5050235191 @default.
- W4206132389 hasAuthorship W4206132389A5055909207 @default.
- W4206132389 hasAuthorship W4206132389A5056658906 @default.
- W4206132389 hasAuthorship W4206132389A5065578155 @default.
- W4206132389 hasAuthorship W4206132389A5066253784 @default.
- W4206132389 hasAuthorship W4206132389A5067969166 @default.
- W4206132389 hasAuthorship W4206132389A5070449446 @default.
- W4206132389 hasAuthorship W4206132389A5075545081 @default.
- W4206132389 hasAuthorship W4206132389A5079216912 @default.
- W4206132389 hasAuthorship W4206132389A5080426159 @default.
- W4206132389 hasAuthorship W4206132389A5085032736 @default.
- W4206132389 hasBestOaLocation W42061323892 @default.
- W4206132389 hasConcept C104317684 @default.
- W4206132389 hasConcept C126322002 @default.
- W4206132389 hasConcept C141071460 @default.
- W4206132389 hasConcept C143998085 @default.
- W4206132389 hasConcept C185592680 @default.
- W4206132389 hasConcept C2776611710 @default.
- W4206132389 hasConcept C2776694085 @default.
- W4206132389 hasConcept C2776938808 @default.
- W4206132389 hasConcept C2779122487 @default.
- W4206132389 hasConcept C2989005 @default.
- W4206132389 hasConcept C509974204 @default.
- W4206132389 hasConcept C529278444 @default.
- W4206132389 hasConcept C55493867 @default.
- W4206132389 hasConcept C71924100 @default.
- W4206132389 hasConceptScore W4206132389C104317684 @default.
- W4206132389 hasConceptScore W4206132389C126322002 @default.
- W4206132389 hasConceptScore W4206132389C141071460 @default.
- W4206132389 hasConceptScore W4206132389C143998085 @default.
- W4206132389 hasConceptScore W4206132389C185592680 @default.
- W4206132389 hasConceptScore W4206132389C2776611710 @default.
- W4206132389 hasConceptScore W4206132389C2776694085 @default.
- W4206132389 hasConceptScore W4206132389C2776938808 @default.
- W4206132389 hasConceptScore W4206132389C2779122487 @default.
- W4206132389 hasConceptScore W4206132389C2989005 @default.
- W4206132389 hasConceptScore W4206132389C509974204 @default.
- W4206132389 hasConceptScore W4206132389C529278444 @default.
- W4206132389 hasConceptScore W4206132389C55493867 @default.
- W4206132389 hasConceptScore W4206132389C71924100 @default.
- W4206132389 hasIssue "1" @default.
- W4206132389 hasLocation W42061323891 @default.
- W4206132389 hasLocation W42061323892 @default.
- W4206132389 hasLocation W42061323893 @default.
- W4206132389 hasOpenAccess W4206132389 @default.
- W4206132389 hasPrimaryLocation W42061323891 @default.
- W4206132389 hasRelatedWork W124022165 @default.
- W4206132389 hasRelatedWork W1985976393 @default.
- W4206132389 hasRelatedWork W2068833234 @default.
- W4206132389 hasRelatedWork W2069157449 @default.